The recent discontinuation of commercially available acyclovir oral suspension is expected to create an unmet need for a vital medication. PCCA is providing this acyclovir oral suspension formulation as an alternative medication option.

Our Acyclovir 200 mg/5 mL Oral Suspension (SuspendIt) formula currently provides a 60-day BUD studied with a stability-indicating assay. Stability studies remain ongoing to potentially provide for longer BUDs; additional data will be shared as it becomes available.

Get the Formula

Complete the following form, and you will immediately receive an email with a link to download the Acyclovir 200 mg/5 mL Oral Suspension formula and stability report.

*Your contact information will not be used for future marketing purposes. 

Contact PCCA with questions regarding acquiring the SuspendIt oral suspension base — email [email protected] or call 800.668.9453.

Looking for a pharmacy to compound this medication? Visit Find A Compounder.

Additional Resources